NCT07640282 ESP Block vs. EXORA Block for Postoperative Pain in Nephrectomy
| NCT ID | NCT07640282 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Bakirkoy Dr. Sadi Konuk Research and Training Hospital |
| Condition | Postoperative Pain |
| Study Type | OBSERVATIONAL |
| Enrollment | 84 participants |
| Start Date | 2026-06 |
| Primary Completion | 2029-08 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 84 participants in total. It began in 2026-06 with a primary completion date of 2029-08.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The goal of this observational study is to learn about the effects of two pain control techniques used after laparoscopic nephrectomy (kidney removal surgery) in adults. The study will compare Erector Spinae Plane (ESP) block and External Oblique Rectus Abdominis (EXORA) block, which are both used as part of routine medical care to help control pain after surgery. The main questions it aims to answer are: Do ESP block and EXORA block differ in how well they control pain after surgery? Do ESP block and EXORA block differ in their effects on recovery quality and the need for additional pain medication? Researchers will compare participants who receive ESP block with participants who receive EXORA block as part of routine clinical care. Participants will: Undergo laparoscopic nephrectomy according to routine clinical practice. Receive either ESP block or EXORA block based on the treating anesthesiologist's usual clinical preference. Complete a recovery questionnaire before surgery and 24 hours after surgery. Have pain scores, use of additional pain medication, nausea and vomiting, and other routine postoperative measurements recorded during the first 24 hours after surgery.
Eligibility Criteria
Inclusion Criteria: * Age between 18 and 80 years * Patients scheduled for laparoscopic nephrectomy * Patients for whom Erector Spinae Plane (ESP) block or External Oblique Rectus Abdominis (EXORA) block has been selected by the treating clinician * ASA physical status I-III Exclusion Criteria: * No regional block performed in routine clinical practice * Body mass index (BMI) greater than 35 kg/m² * History of opioid dependence * Alcohol or other substance dependence * Psychiatric disease, mental retardation, dementia, or any condition impairing pain perception or pain assessment
Contact & Investigator
Frequently Asked Questions
Who can join the NCT07640282 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 80 Years, studying Postoperative Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07640282 currently recruiting?
Yes, NCT07640282 is actively recruiting participants. Contact the research team at snurguner@gmail.com for enrollment information.
Where is the NCT07640282 trial being conducted?
This trial is being conducted at Istanbul, Turkey (Türkiye).
Who is sponsoring the NCT07640282 clinical trial?
NCT07640282 is sponsored by Bakirkoy Dr. Sadi Konuk Research and Training Hospital. The trial plans to enroll 84 participants.